Search Results - "Byer, Stephanie"
-
1
4-Hydroxytamoxifen Induces Autophagic Death through K-Ras Degradation
Published in Cancer research (Chicago, Ill.) (15-07-2013)“…Tamoxifen is widely used to treat estrogen receptor-positive breast cancer. Recent findings that tamoxifen and its derivative 4-hydroxytamoxifen (OHT) can…”
Get full text
Journal Article -
2
Combinatorial Therapy With Tamoxifen and Trifluoperazine Effectively Inhibits Malignant Peripheral Nerve Sheath Tumor Growth by Targeting Complementary Signaling Cascades
Published in Journal of neuropathology and experimental neurology (01-11-2014)“…ABSTRACTChemotherapeutic agents effective against malignant peripheral nerve sheath tumors (MPNSTs) are urgently needed. We recently found that tamoxifen…”
Get full text
Journal Article -
3
Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells
Published in Journal of neuropathology and experimental neurology (01-06-2015)“…Neurofibromin, the tumor suppressor encoded by the neurofibromatosis type 1 (NF1) gene, potentially suppresses the activation of H-Ras, N-Ras, and K-Ras…”
Get full text
Journal Article -
4
Transgenic Mice Overexpressing Neuregulin-1 Model Neurofibroma-Malignant Peripheral Nerve Sheath Tumor Progression and Implicate Specific Chromosomal Copy Number Variations in Tumorigenesis
Published in The American journal of pathology (01-03-2013)“…Patients with neurofibromatosis type 1 (NF1) develop benign plexiform neurofibromas that frequently progress to become malignant peripheral nerve sheath tumors…”
Get full text
Journal Article -
5
Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis
Published in Acta neuropathologica (01-04-2014)“…Malignant peripheral nerve sheath tumors (MPNSTs) are Schwann cell-derived malignancies that arise from plexiform neurofibromas in patients with mutation of…”
Get full text
Journal Article -
6
Neuregulin-1β and neuregulin-1α differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells
Published in Glia (01-11-2009)“…Malignant peripheral nerve sheath tumors (MPNSTs) are the most common malignancy associated with neurofibromatosis Type 1 (NF1). These Schwann cell…”
Get full text
Journal Article -
7
Malignant Peripheral Nerve Sheath Tumor Invasion Requires Aberrantly Expressed EGF Receptors and Is Variably Enhanced by Multiple EGF Family Ligands
Published in Journal of neuropathology and experimental neurology (01-03-2013)“…ABSTRACTAberrant epidermal growth factor receptor (EGFR) expression promotes the pathogenesis of malignant peripheral nerve sheath tumors (MPNSTs), the most…”
Get full text
Journal Article -
8
Activation of the neuregulin-1 ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors
Published in Oncogene (25-08-2005)“…Patients with neurofibromatosis type 1 develop aggressive Schwann cell neoplasms known as malignant peripheral nerve sheath tumors (MPNSTs). Although tumor…”
Get full text
Journal Article -
9
Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner
Published in Neuro-oncology (Charlottesville, Va.) (01-01-2011)“…Few therapeutic options are available for malignant peripheral nerve sheath tumors (MPNSTs), the most common malignancy associated with neurofibromatosis type…”
Get full text
Journal Article -
10
Neuregulin Growth Factors and Their ErbB Receptors Form a Potential Signaling Network for Schwannoma Tumorigenesis
Published in Journal of neuropathology and experimental neurology (01-02-2006)“…Sporadic and neurofibromatosis type 2-associated schwannomas contain a glial growth factor (GGF)-like activity that has been hypothesized to promote neoplastic…”
Get full text
Journal Article -
11
Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents
Published in Journal of visualized experiments (07-03-2011)“…Although in vitro screens are essential for the initial identification of candidate therapeutic agents, a rigorous assessment of the drug's ability to inhibit…”
Get full text
Journal Article -
12
Ganglion-Specific Patterns of Diabetes-Modulated Gene Expression Are Established in Prevertebral and Paravertebral Sympathetic Ganglia Prior to the Development of Neuroaxonal Dystrophy
Published in Journal of neuropathology and experimental neurology (01-11-2004)“…In both humans and animal models, diabetic sympathetic autonomic neuropathy is associated with the selective development of markedly enlarged distal axons and…”
Get full text
Journal Article -
13
R‐Ras Subfamily Proteins Elicit Distinct Physiologic Effects and Phosphoproteome Alterations in Neurofibromin‐Null MPNST Cells
Published in The FASEB journal (01-04-2016)“…Abstract only Loss of the Ras GTPase‐activating protein neurofibromin promotes the development of multiple nervous system tumors in patients with the genetic…”
Get full text
Journal Article -
14
Overexpression of the lysophosphatidic acid generating enzyme autotaxin/ENPP2 potentially promotes the pathogenesis of neurofibromatosis type 1‐associated neurofibromas and malignant peripheral nerve sheath tumors
Published in The FASEB journal (01-04-2013)“…Abstract only Aggressive Schwann cell‐derived sarcomas known as malignant peripheral nerve sheath tumors (MPNSTs) are the leading cause of death in patients…”
Get full text
Journal Article -
15
LPA and NRG‐1b synergistically promote proliferation and migration of wild‐type and neoplastic Schwann cells via an ERRFI1‐dependent mechanism
Published in The FASEB journal (01-04-2009)“…Abstract only…”
Get full text
Journal Article -
16
Neuregulin‐1 overexpression and p53 haploinsufficiency cooperatively promote de novo MPNST pathogenesis
Published in The FASEB journal (01-04-2013)“…Abstract only Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas arising from neurofibromas in patients with neurofibromatosis type 1…”
Get full text
Journal Article -
17
Malignant Peripheral Nerve Sheath Tumor Invasion Requires Aberrantly Expressed Epidermal Growth Factor (EGF) Receptors and is Variably Enhanced by Multiple EGF Family Ligands
Published in Journal of neuropathology and experimental neurology (01-03-2013)“…Aberrant epidermal growth factor receptor (EGFR) expression promotes the pathogenesis of malignant peripheral nerve sheath tumors (MPNSTs), the most common…”
Get full text
Journal Article -
18
4-hydroxy-tamoxifen induces autophagic death through K-Ras degradation
Published in Cancer research (Chicago, Ill.) (30-05-2013)“…Tamoxifen is widely used to treat estrogen receptor (ER)-positive breast cancer. Recent findings that tamoxifen and its derivative 4-dehydroxy-tamoxifen (OHT)…”
Get full text
Journal Article -
19
Tamoxifen inhibits the proliferation and survival of malignant peripheral nerve sheath tumor cells via an estrogen receptor‐independent mechanism
Published in The FASEB journal (01-04-2009)“…Abstract only…”
Get full text
Journal Article -
20
Neuregulin-1b and neuregulin-1a differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells
Published in Glia (01-11-2009)“…Malignant peripheral nerve sheath tumors (MPNSTs) are the most common malignancy associated with neurofibromatosis Type 1 (NF1). These Schwann cell…”
Get full text
Journal Article